未登录

N

Nina Rågård

contribution: visualization, writing - review & editing

H指数:5

被引数:175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

精选封面

Alimentary Pharmacology & Therapeutics

IF6.7

2025-12-290

OAAI

Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study

通过经验性供体选择和优化剂量改进难辨梭菌感染中包埋粪菌移植的临床疗效：一项质量改进研究

Alimentary Pharmacology & Therapeutics

IF6.7

2025-10-060

OAAI

Clinical management of Clostridioides difficile infection with faecal microbiota transplantation: a real-world cohort study

艰难梭菌感染的临床管理：粪菌移植的真实世界队列研究

eClinicalMedicine

IF10

2025-07-010

PRE

Validation methods for encapsulated faecal microbiota transplantation: a scoping review

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

IF3.4

2025-02-080

OAAI

Encapsulated donor faeces for faecal microbiota transplantation: the Glyprotect protocol

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

IF3.4

2024-10-132

OAAI

Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation. Authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2023-10-130

OAAI

Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2023-07-226

OAAI

Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection Reply

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2023-02-013

PRE

Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2022-12-0160

PRE